Status: Not yet recruiting
Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy
This study intends to carry out prospective, randomized controlled clinical trials in many centers across the country to compare the efficacy and safety of immunotherapy after standard first-line chemotherapy or immunotherapy combined with interventional bronchial artery chemoembolization for stage IV lung squamous cell carcinoma.
Participants needed: 166
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyUpdated: May 5, 2026
Eligibility criteria
Squamous cell carcinoma of the lung confirmed by histology or cytology; [+11]
There is epidermal growth factor receptor (EGFR) sensitive mutation or anaplasti... [+9]